Six studies, including 1187 participants, examined the association between Gd-IgA1 levels and risk of CKD progression (defined by sustained > 30% irreversible decline in eGFR [34] or progression of CKD stage according to the KDIGO guideline [31, 33, 39, 51, 55]). The gene discussed is IGHA1; the disease is chronic kidney disease.